LOCUS       NP_036679                444 aa                     ROD 10-AUG-2014
DEFINITION  D(2) dopamine receptor [Rattus norvegicus].
ACCESSION   NP_036679
VERSION     NP_036679.1  GI:6978777
KEYWORDS    RefSeq.
SOURCE      Rattus norvegicus (Norway rat)
  ORGANISM  Rattus norvegicus
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia;
            Sciurognathi; Muroidea; Muridae; Murinae; Rattus.
REFERENCE   1  (residues 1 to 444)
  AUTHORS   Trantham-Davidson H, Burnett EJ, Gass JT, Lopez MF, Mulholland PJ,
            Centanni SW, Floresco SB and Chandler LJ.
  TITLE     Chronic alcohol disrupts dopamine receptor activity and the
            cognitive function of the medial prefrontal cortex
  JOURNAL   J. Neurosci. 34 (10), 3706-3718 (2014)
   PUBMED   24599469
  REMARK    GeneRIF: Chronic alcohol exposure disrupts dopamine D2 receptor
            activity in medial prefrontal cortex.
REFERENCE   2  (residues 1 to 444)
  AUTHORS   Jia JM, Zhao J, Hu Z, Lindberg D and Li Z.
  TITLE     Age-dependent regulation of synaptic connections by dopamine D2
            receptors
  JOURNAL   Nat. Neurosci. 16 (11), 1627-1636 (2013)
   PUBMED   24121738
  REMARK    GeneRIF: This study demonistrated that Age-dependent regulation of
            synaptic connections by dopamine D2 receptors.
REFERENCE   3  (residues 1 to 444)
  AUTHORS   Dyavanapalli J, Byrne P and Mendelowitz D.
  TITLE     Activation of D2-like dopamine receptors inhibits GABA and
            glycinergic neurotransmission to pre-motor cardiac vagal neurons in
            the nucleus ambiguus
  JOURNAL   Neuroscience 247, 213-226 (2013)
   PUBMED   23727508
  REMARK    GeneRIF: Activation of dopamine D2 receptors inhibits
            gamma-aminobutyric acid (GABA) and glycinergic neurotransmission.
REFERENCE   4  (residues 1 to 444)
  AUTHORS   Chen C, Yang JM, Hu TT, Xu TJ, Xu WP and Wei W.
  TITLE     Elevated dopamine D2 receptor in prefrontal cortex of CUMS rats is
            associated with downregulated cAMP-independent signaling pathway
  JOURNAL   Can. J. Physiol. Pharmacol. 91 (9), 750-758 (2013)
   PUBMED   23984873
  REMARK    GeneRIF: Suggest that elevated prefrontal cortex dopamine D2
            receptors may be involved in mediating the stress response and
            neuronal mechanism of depression.
REFERENCE   5  (residues 1 to 444)
  AUTHORS   Shou Y, Yang Y, Xu MS, Zhao YQ, Ge LB and Zhang BM.
  TITLE     Electroacupuncture inhibition of hyperalgesia in rats with adjuvant
            arthritis: involvement of cannabinoid receptor 1 and dopamine
            receptor subtypes in striatum
  JOURNAL   Evid Based Complement Alternat Med 2013, 393460 (2013)
   PUBMED   23762129
REFERENCE   6  (residues 1 to 444)
  AUTHORS   Livingstone CD, Strange PG and Naylor LH.
  TITLE     Molecular modelling of D2-like dopamine receptors
  JOURNAL   Biochem. J. 287 (PT 1), 277-282 (1992)
   PUBMED   1358063
REFERENCE   7  (residues 1 to 444)
  AUTHORS   Minowa T, Minowa MT and Mouradian MM.
  TITLE     Analysis of the promoter region of the rat D2 dopamine receptor gene
  JOURNAL   Biochemistry 31 (36), 8389-8396 (1992)
   PUBMED   1390623
REFERENCE   8  (residues 1 to 444)
  AUTHORS   Cox BA, Henningsen RA, Spanoyannis A, Neve RL and Neve KA.
  TITLE     Contributions of conserved serine residues to the interactions of
            ligands with dopamine D2 receptors
  JOURNAL   J. Neurochem. 59 (2), 627-635 (1992)
   PUBMED   1321233
REFERENCE   9  (residues 1 to 444)
  AUTHORS   Sokoloff P, Giros B, Martres MP, Bouthenet ML and Schwartz JC.
  TITLE     Molecular cloning and characterization of a novel dopamine receptor
            (D3) as a target for neuroleptics
  JOURNAL   Nature 347 (6289), 146-151 (1990)
   PUBMED   1975644
REFERENCE   10  (residues 1 to 444)
  AUTHORS   Miller JC, Wang Y and Filer D.
  TITLE     Identification by sequence analysis of a second rat brain cDNA
            encoding the dopamine (D2) receptor
  JOURNAL   Biochem. Biophys. Res. Commun. 166 (1), 109-112 (1990)
   PUBMED   2137336
COMMENT     PROVISIONAL REFSEQ: This record has not yet been subject to final
            NCBI review. The reference sequence was derived from X56065.1.
            On Jan 12, 2005 this sequence version replaced gi:34862962.
            Summary: mediates G-protein coupled signaling; may be involved in
            movement disorders, schizophrenia, and drug addiction [RGD, Feb
            2006].
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            ##Evidence-Data-START##
            Transcript exon combination :: X56065.1, X53278.1 [ECO:0000332]
            ##Evidence-Data-END##
FEATURES             Location/Qualifiers
     source          1..444
                     /strain="Sprague-Dawley"
                     /map="8q24"
                     /organism="Rattus norvegicus"
                     /chromosome="8"
                     /db_xref="taxon:10116"
     Protein         1..444
                     /note="dopamine receptor 2"
                     /product="D(2) dopamine receptor"
                     /calculated_mol_wt="50773"
     Site            38..60
                     /note="propagated from UniProtKB/Swiss-Prot (P61169.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          45..>233
                     /note="Serpentine type 7TM GPCR chemoreceptor Srsx;
                     pfam10320"
                     /db_xref="CDD:255903"
                     /region_name="7TM_GPCR_Srsx"
     Region          57..427
                     /note="7 transmembrane receptor (rhodopsin family);
                     pfam00001"
                     /db_xref="CDD:249497"
                     /region_name="7tm_1"
     Site            71..93
                     /note="propagated from UniProtKB/Swiss-Prot (P61169.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            109..130
                     /note="propagated from UniProtKB/Swiss-Prot (P61169.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            152..172
                     /note="propagated from UniProtKB/Swiss-Prot (P61169.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            189..213
                     /note="propagated from UniProtKB/Swiss-Prot (P61169.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          190..197
                     /note="propagated from UniProtKB/Swiss-Prot (P61169.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /region_name="Agonist binding (By similarity)"
     Site            194
                     /note="Important for receptor activation; propagated from
                     UniProtKB/Swiss-Prot (P61169.1)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /site_type="other"
     Site            197
                     /note="Important for receptor activation; propagated from
                     UniProtKB/Swiss-Prot (P61169.1)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /site_type="other"
     Region          211..374
                     /note="propagated from UniProtKB/Swiss-Prot (P61169.1)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /region_name="Interaction with PPP1R9B"
     Site            375..396
                     /note="propagated from UniProtKB/Swiss-Prot (P61169.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          387..395
                     /note="propagated from UniProtKB/Swiss-Prot (P61169.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /region_name="Agonist binding (By similarity)"
     Site            411..432
                     /note="propagated from UniProtKB/Swiss-Prot (P61169.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     CDS             1..444
                     /coded_by="NM_012547.1:347..1681"
                     /gene="Drd2"
                     /db_xref="GeneID:24318"
                     /db_xref="RGD:2520"
ORIGIN
        1 mdplnlswyd ddlerqnwsr pfngsegkad rphynyyaml ltllifiivf gnvlvcmavs
       61 rekalqtttn ylivslavad llvatlvmpw vvylevvgew kfsrihcdif vtldvmmcta
      121 silnlcaisi drytavampm lyntrysskr rvtvmiaivw vlsftiscpl lfglnntdqn
      181 eciianpafv vyssivsfyv pfivtllvyi kiyivlrkrr krvntkrssr afranlktpl
      241 kgncthpedm klctvimksn gsfpvnrrrm daarraqele memlsstspp ertryspipp
      301 shhqltlpdp shhglhsnpd spakpekngh akivnpriak ffeiqtmpng ktrtslktms
      361 rrklsqqkek katqmlaivl gvfiicwlpf fithilnihc dcnippvlys aftwlgyvns
      421 avnpiiyttf niefrkafmk ilhc
//
